Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid is a drugstore chain that offers prescription medications, over-the-counter drugs, and health and wellness products. Rite Aid is reshaping the concept of a modern pharmacy by catering to customer demands through various convenient channels, including retail and delivery pharmacy services. Additionally, the company's offerings extend to services provided by its wholly-owned subsidiaries, namely Elixir, Bartell Drugs, and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, encompasses accredited mail and specialty pharmacies, prescription discount programs, and an advanced adjudication platform. These components combine to provide exceptional member experiences and substantial cost savings. Furthermore, Health Dialog delivers healthcare coaching and disease management services through interactive live online sessions and phone-based health services.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

Here's why Rite Aid could be rising Thursday morning, and what investors should keep in mind.

Why Rite Aid Shares Could Be Up Another 11% Thursday

Cohu

Innovative Industrial Properties

SP Plus

Ultra Clean

A trade deal with high prospects, low interest rate environment and the rising US economy make the investment scenario look attractive for 2020.

5 Must-Buy Small-Cap Stocks for a Steady Rally in 2020

Rite Aid said Medicare Part D numbers will jump by 140,000 to 840,000 come January 1, 2020 after a successful open enrollment period that just completed.

Rite Aid’s PBM Critical To 2020 Turnaround Strategy

Rite Aid (RAD) shares rose 7% in the last trading session, amid huge volumes.

Rite Aid (RAD) in Focus: Stock Moves 7% Higher

Rite Aid (RAD) posts robust results in third-quarter fiscal 2020. Notably, the bottom line benefits from higher adjusted EBITDA in the quarter.

Rite Aid (RAD) Earnings Surpass Estimates in Q3, Stock Up

Shares were rallying following a strong earnings report.

Why Rite Aid Stock Surged Today (RAD)

A big earnings beat and better-than-expected guidance led to a big day for the pharmacy retail stock.

Rite Aid Soars After Earnings: 3 Takeaways From the Company's Third-Quarter Results

Tesla

General Mills

Medifast

General Mills, Tesla, Rite Aid and Medifast were our top stock trades from Thursday. Let's look at the charts going into Friday.

4 Top Stock Trades for Friday: TSLA, RAD, GIS, MED

Rite Aid (RAD) earnings for the U.S. pharmacy company's third quarter of fiscal 2020 have RAD stock flying high on Thursday.

Rite Aid Earnings: RAD Stock Rockets 43% Higher on Better-Than-Expected Q3

Rite Aid Corporation (RAD) CEO Heyward Donigan on Q3 2020 Results - Earnings Call Transcript

Rite Aid crushed earnings estimates for the third quarter and guided higher than the Street for full-year 2020. Rite Aid stock soared.

Rite Aid Stock Hasn't Done This Well Since Before Apple Launched The First Mac

Better-than-expected Q3 results have investors fired up.

Why Rite Aid Stock Is Skyrocketing Today

Rite Aid Corp. (NYSE: RAD) reported fiscal third-quarter 2020 results before markets opened Thursday.

How Rite Aid Surprised Investors With Q3 Earnings

Though it’s just four months in the reign of Heyward Donigan, the new chief executive officer said Thursday the drugstore chain’s outlook is improving even as Rite Aid, like other drugstore chains, continues to face reimbursement pressures for prescription drugs.

Rite Aid CEO: Turn Around ‘Will Take Some Time’

Rite Aid (RAD) delivered earnings and revenue surprises of 1700.00% and 0.64%, respectively, for the quarter ended November 2019. Do the numbers hold clues to what lies ahead for the stock?

Rite Aid (RAD) Q3 Earnings and Revenues Top Estimates

Rite Aid Corporation (NYSE: RAD) shares are trading sharply higher on Thursday after the company reported better-than-expected third quarter EPS and sales results.

Rite Aid Reports Q3 Earnings Beat, Raises Guidance; Shares Up 20%

Rite Aid Corp. RAD, +8.47% stock soared more than 20.6% in Thursday premarket trading after the pharmacy retailer swung to a third-quarter profit and beat expectations.

Rite Aid shares skyrocket 20% after earnings beat

On Thursday, December 19, Rite Aid (NYSE: RAD) will release its latest earnings report.

Q3 Earnings Preview For Rite Aid

Blue Apron

Destination XL Group

These once-profitable retail stocks have reached penny-stock status due to declining sales and financials that continue to deteriorate.

7 of the Worst Retail Stocks That Refuse to Die

Nordstrom

Bed Bath & Beyond

Chico's FAS

Guess?

Golden crosses and death crosses are common signals in technical analysis and refer to the relationship between short-term and long-term moving averages.

Nordstrom, Rite Aid and Other Retail Stocks With Recent Golden Crosses

Rite Aid's (RAD) third-quarter fiscal 2020 results are expected to reflect progress on its growth strategy. Weak front-end same-store sales and Retail Pharmacy segment might have been drags.

Rite Aid (RAD) to Report Q3 Earnings: What's in the Cards?

In the latest trading session, Rite Aid (RAD) closed at $8.08, marking a -0.25% move from the previous day.

Rite Aid (RAD) Dips More Than Broader Markets: What You Should Know

Beyond Meat

Johnson & Johnson

Shopify

Spotify

Tilray Brands

These stocks to sell will likely face pain in 2020 as these equities face worsening conditions and increasing financial and market pressure.

7 Unsteady Stocks Investors Should Consider Selling Before 2020

Aurora Cannabis

Chesapeake Energy

Gannett Co.

Soliton

These 5 stocks all have a real chance of winding up at zero — but if they can avoid that outcome, they could easily triple or more.

5 Lottery Stocks With Huge Upside — And a Real Chance of $0

Alphabet

AT&T

Wednesday's 3 big stock charts highlight recent market winners whose rallies may be petering out.
The post 3 Big Stock Charts for Wednesday: Alphabet, AT&T, and Rite Aid appeared first on InvestorPlace.

News for Rite Aid Stock (RAD)